BRG Borregaard

Borregaard ASA: Operational issues at Sarpsborg site will affect 4th quarter result

Borregaard ASA: Operational issues at Sarpsborg site will affect 4th quarter result

During the 4th quarter 2019, operational incidents have affected production at the Sarpsborg site. The negative impact on EBITA adj.¹ is estimated to be NOK 30-40 million, mainly in Speciality Cellulose.

Leakages in the water supply system have resulted in reduced production volume and declassified speciality cellulose products have been sold at lower prices. The issues have now been solved, and there will only be minor carry-over effects to the 1st quarter of 2020.

Sarpsborg, 16.12.19

Contacts:

Director Investor Relations, Jørn Syvertsen,  335

Communication Manager, Tone Horvei Bredal,

1. Operating profit before amortisation and other income and expenses

This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

EN
16/12/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Borregaard

 PRESS RELEASE

Borregaard ASA: Issuance of Commercial Paper

Borregaard ASA: Issuance of Commercial Paper Borregaard ASA has issued a commercial paper ISIN NO0013708651 of NOK 100,000,000. Start date: 12 December, 2025Maturity: 12 February, 2026Coupon: 4,43 %Organised by: DNB Carnegie Sarpsborg, 10 December 2025 Contact:CFO, Per Bjarne Lyngstad, +47 952 44 515 This information is subject to the disclosure requirements pursuant to Section 5 -12 of the Norwegian Securities Trading Act.  

ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Henrik Bartnes
  • Martin Melbye
ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Henrik Bartnes
  • Martin Melbye
 PRESS RELEASE

Borregaard ASA: EBITDA1 of NOK 440 million in the 3rd quarter

Borregaard ASA: EBITDA1 of NOK 440 million in the 3rd quarter Borregaard’s operating revenues were NOK 1,799 million (NOK 1,949 million)2 in the 3rd quarter of 2025. EBITDA1 was NOK 440 million (NOK 524 million). The result in BioSolutions increased while BioMaterials and Fine Chemicals had lower results compared with the 3rd quarter of 2024. The reduced EBITDA1 was due to lower bioethanol prices and the temporary disruption in cellulose production at the Sarpsborg site. The negative impact from this disruption amounts to approximately NOK 40 million. The improvement in the result for BioS...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch